Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aef0117 (6 trials)
aef0217 (2 trials)
Marijuana Abuse (Phase 2)
Trials (8 total)
Trial APIs (2 total)